Related Experiment Video
Updated: Oct 7, 2025

Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
RNF12 is regulated by AKT phosphorylation and promotes TGF-β driven breast cancer metastasis
Yongsheng Huang1,2, Sijia Liu3, Mengjie Shan4
1Institute of Basic Medical Sciences and School of Basic Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China. yongsheng@ibms.pumc.edu.
Abstract:
Transforming growth factor-β (TGF-β) acts as a pro-metastatic factor in advanced breast cancer. RNF12, an E3 ubiquitin ligase, stimulates TGF-β signaling by binding to the inhibitory SMAD7 and inducing its proteasomal degradation. How RNF12 activity is regulated and its exact role in cancer is incompletely understood. Here we report that RNF12 was overexpressed in invasive breast cancers and its high expression correlated with poor prognosis. RNF12 promoted breast cancer cell migration, invasion, and experimental metastasis in zebrafish and murine xenograft models. RNF12 levels were positively associated with the phosphorylated AKT/protein kinase B (PKB) levels, and both displayed significant higher levels in the basal-like subtype compared with the levels in luminal-like subtype of breast cancer cells. Mechanistically, AKT-mediated phosphorylation induced the nuclear localization of RNF12, maintained its stability, and accelerated the degradation of SMAD7 mediated by RNF12. Furthermore, we demonstrated that RNF12 and AKT cooperated functionally in breast cancer cell migration. Notably, RNF12 expression strongly correlated with both phosphorylated AKT and phosphorylated SMAD2 levels in breast cancer tissues. Thus, our results uncovered RNF12 as an important determinant in the crosstalk between the TGF-β and AKT signaling pathways during breast cancer progression.
Insights
High RNF12 expression promotes breast cancer metastasis by enhancing TGF-β signaling via AKT. RNF12 overexpression correlates with poor prognosis and invasiveness in breast cancer patients.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-β (TGF-β) is a key driver of metastasis in advanced breast cancer.
- RNF12, an E3 ubiquitin ligase, enhances TGF-β signaling by degrading SMAD7, but its regulation and role in cancer remain unclear.
Purpose of the Study:
- To investigate the role of RNF12 in breast cancer progression and its regulation by AKT signaling.
- To elucidate the mechanistic link between RNF12, AKT, and TGF-β pathways in breast cancer metastasis.
Main Methods:
- Analysis of RNF12 expression in human breast cancer tissues and correlation with prognosis.
- In vitro studies using breast cancer cell lines to assess migration, invasion, and metastasis.
- Zebrafish and murine xenograft models for experimental metastasis.
- Western blotting and immunofluorescence to determine protein levels, localization, and interactions.
Main Results:
- RNF12 is overexpressed in invasive breast cancers, correlating with poor prognosis.
- High RNF12 expression promotes breast cancer cell migration, invasion, and metastasis in vivo.
- AKT-mediated phosphorylation of RNF12 enhances its stability, nuclear localization, and SMAD7 degradation.
- RNF12 and AKT signaling pathways cooperate in promoting breast cancer cell migration.
- RNF12 expression correlates with phosphorylated AKT and SMAD2 in patient tissues.
Conclusions:
- RNF12 is a critical mediator of breast cancer progression and metastasis.
- The AKT-mediated regulation of RNF12 highlights a crucial crosstalk between AKT and TGF-β signaling.
- RNF12 represents a potential therapeutic target for aggressive breast cancer subtypes.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
TGF - β Signaling Pathway
MAPK Signaling Cascades
Regulation of Angiogenesis and Blood Supply
NF-κB-dependent Signaling Pathway
NF-κB-dependent Signaling Mechanism
The...

